Matches in SemOpenAlex for { <https://semopenalex.org/work/W2408291231> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2408291231 endingPage "52" @default.
- W2408291231 startingPage "1145" @default.
- W2408291231 abstract "The efficacy of the combination chemoendocrine therapy CAUT against advanced and recurrent breast cancer was examined. One course of this therapy lasted 3 weeks and consisted of adriamycin (i.v.) at 30 mg/m2 on day 1, cyclophosphamide (p.o.) at 65 mg/m2 and UFT (p.o.) at 300 mg/m2 on days 1-14, and tamoxifen (p.o.) at 20 mg/body on days 1-21. Twenty patients were enrolled, of whom 19 were eligible including seven with advanced cancer and 12 with recurrent cancer. One patient achieved CR, ten PR, three NC, and five PD, for a response rate of 58% (95% CI: 29-87%). The response rates according to type of lesion were 73% (8/11) for the soft tissue, 38% (3/8) for the bone, 20% (1/5) for the lungs and pleura, and 50% (2/4) for the liver. Adverse events with a severity of grade 3 or more included a reduction in WBC in six patients (31.6%), a reduction in RBC in one (5.3%), alopecia in four (21.1%), and severe general fatigue in one (5.3%). One patient experiencing a grade 4 reduction in WBC, and one of five patients experiencing a grade 3 reduction with a fever, recovered after treatment with G-CSF. The other four patients recovered following suspension of administration. This therapy is considered useful, exhibiting a high response rate and relatively slight adverse effects." @default.
- W2408291231 created "2016-06-24" @default.
- W2408291231 creator A5002454208 @default.
- W2408291231 creator A5014903064 @default.
- W2408291231 creator A5015369027 @default.
- W2408291231 creator A5019295458 @default.
- W2408291231 creator A5024776126 @default.
- W2408291231 creator A5031230287 @default.
- W2408291231 creator A5058098685 @default.
- W2408291231 creator A5073748423 @default.
- W2408291231 creator A5079709770 @default.
- W2408291231 date "1999-07-01" @default.
- W2408291231 modified "2023-09-24" @default.
- W2408291231 title "[A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer]." @default.
- W2408291231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10431580" @default.
- W2408291231 hasPublicationYear "1999" @default.
- W2408291231 type Work @default.
- W2408291231 sameAs 2408291231 @default.
- W2408291231 citedByCount "1" @default.
- W2408291231 crossrefType "journal-article" @default.
- W2408291231 hasAuthorship W2408291231A5002454208 @default.
- W2408291231 hasAuthorship W2408291231A5014903064 @default.
- W2408291231 hasAuthorship W2408291231A5015369027 @default.
- W2408291231 hasAuthorship W2408291231A5019295458 @default.
- W2408291231 hasAuthorship W2408291231A5024776126 @default.
- W2408291231 hasAuthorship W2408291231A5031230287 @default.
- W2408291231 hasAuthorship W2408291231A5058098685 @default.
- W2408291231 hasAuthorship W2408291231A5073748423 @default.
- W2408291231 hasAuthorship W2408291231A5079709770 @default.
- W2408291231 hasConcept C121608353 @default.
- W2408291231 hasConcept C126322002 @default.
- W2408291231 hasConcept C126894567 @default.
- W2408291231 hasConcept C141071460 @default.
- W2408291231 hasConcept C197934379 @default.
- W2408291231 hasConcept C2776694085 @default.
- W2408291231 hasConcept C2776755627 @default.
- W2408291231 hasConcept C2776999253 @default.
- W2408291231 hasConcept C2777176818 @default.
- W2408291231 hasConcept C530470458 @default.
- W2408291231 hasConcept C71924100 @default.
- W2408291231 hasConcept C90924648 @default.
- W2408291231 hasConceptScore W2408291231C121608353 @default.
- W2408291231 hasConceptScore W2408291231C126322002 @default.
- W2408291231 hasConceptScore W2408291231C126894567 @default.
- W2408291231 hasConceptScore W2408291231C141071460 @default.
- W2408291231 hasConceptScore W2408291231C197934379 @default.
- W2408291231 hasConceptScore W2408291231C2776694085 @default.
- W2408291231 hasConceptScore W2408291231C2776755627 @default.
- W2408291231 hasConceptScore W2408291231C2776999253 @default.
- W2408291231 hasConceptScore W2408291231C2777176818 @default.
- W2408291231 hasConceptScore W2408291231C530470458 @default.
- W2408291231 hasConceptScore W2408291231C71924100 @default.
- W2408291231 hasConceptScore W2408291231C90924648 @default.
- W2408291231 hasIssue "8" @default.
- W2408291231 hasLocation W24082912311 @default.
- W2408291231 hasOpenAccess W2408291231 @default.
- W2408291231 hasPrimaryLocation W24082912311 @default.
- W2408291231 hasRelatedWork W1963742939 @default.
- W2408291231 hasRelatedWork W2000776622 @default.
- W2408291231 hasRelatedWork W2067315216 @default.
- W2408291231 hasRelatedWork W2122952702 @default.
- W2408291231 hasRelatedWork W2408291231 @default.
- W2408291231 hasRelatedWork W2414405287 @default.
- W2408291231 hasRelatedWork W318327700 @default.
- W2408291231 hasRelatedWork W3211231495 @default.
- W2408291231 hasRelatedWork W2182927092 @default.
- W2408291231 hasRelatedWork W2734658215 @default.
- W2408291231 hasVolume "26" @default.
- W2408291231 isParatext "false" @default.
- W2408291231 isRetracted "false" @default.
- W2408291231 magId "2408291231" @default.
- W2408291231 workType "article" @default.